These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20717166)

  • 21. Rubinstein-Taybi syndrome in Chinese population with four novel mutations.
    Yu PT; Luk HM; Lo IFM
    Am J Med Genet A; 2021 Jan; 185(1):267-273. PubMed ID: 33063428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells.
    Dutto I; Scalera C; Tillhon M; Ticli G; Passaniti G; Cazzalini O; Savio M; Stivala LA; Gervasini C; Larizza L; Prosperi E
    Carcinogenesis; 2020 May; 41(3):257-266. PubMed ID: 31504229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype.
    Menke LA; van Belzen MJ; Alders M; Cristofoli F; ; Ehmke N; Fergelot P; Foster A; Gerkes EH; Hoffer MJ; Horn D; Kant SG; Lacombe D; Leon E; Maas SM; Melis D; Muto V; Park SM; Peeters H; Peters DJ; Pfundt R; van Ravenswaaij-Arts CM; Tartaglia M; Hennekam RC
    Am J Med Genet A; 2016 Oct; 170(10):2681-93. PubMed ID: 27311832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints.
    Gervasini C; Castronovo P; Bentivegna A; Mottadelli F; Faravelli F; Giovannucci-Uzielli ML; Pessagno A; Lucci-Cordisco E; Pinto AM; Salviati L; Selicorni A; Tenconi R; Neri G; Larizza L
    Genomics; 2007 Nov; 90(5):567-73. PubMed ID: 17855048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders.
    Negri G; Magini P; Milani D; Crippa M; Biamino E; Piccione M; Sotgiu S; Perrìa C; Vitiello G; Frontali M; Boni A; Di Fede E; Gandini MC; Colombo EA; Bamshad MJ; Nickerson DA; Smith JD; Loddo I; Finelli P; Seri M; Pippucci T; Larizza L; Gervasini C
    Hum Genet; 2019 Mar; 138(3):257-269. PubMed ID: 30806792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein-Taybi Syndrome kids with high frequency of polydactyly.
    Yu S; Wu B; Qian Y; Zhang P; Lu Y; Dong X; Wang Q; Zhao X; Liu R; Zhou W; Wang H
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1009. PubMed ID: 31637876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.
    Bartsch O; Schmidt S; Richter M; Morlot S; Seemanová E; Wiebe G; Rasi S
    Hum Genet; 2005 Sep; 117(5):485-93. PubMed ID: 16021471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identical EP300 variant leading to Rubinstein-Taybi syndrome with different clinical and immunologic phenotype.
    Saettini F; Fazio G; Bonati MT; Moratto D; Massa V; Di Fede E; Castiglioni S; Marchetti D; Chiarini M; Sottini A; Iascone M; Cazzaniga G; Imberti L; Biondi A; Gervasini C; Badolato R
    Am J Med Genet A; 2022 Jul; 188(7):2129-2134. PubMed ID: 35266289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
    Korzus E
    Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum.
    Hamilton MJ; Newbury-Ecob R; Holder-Espinasse M; Yau S; Lillis S; Hurst JA; Clement E; Reardon W; Joss S; Hobson E; Blyth M; Al-Shehhi M; Lynch SA; Suri M;
    Clin Dysmorphol; 2016 Oct; 25(4):135-45. PubMed ID: 27465822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability.
    Alari V; Russo S; Terragni B; Ajmone PF; Sironi A; Catusi I; Calzari L; Concolino D; Marotta R; Milani D; Giardino D; Mantegazza M; Gervasini C; Finelli P; Larizza L
    Stem Cell Res; 2018 Jul; 30():130-140. PubMed ID: 29883886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia.
    Huang X; Rui X; Zhang S; Qi X; Rong W; Sheng X
    BMC Med Genomics; 2023 Apr; 16(1):84. PubMed ID: 37085840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case with Rubinstein-Taybi syndrome: A novel frameshift mutation in the CREBBP gene.
    Eser M; Ayaz A; Yeşil G
    Turk J Pediatr; 2017; 59(5):601-603. PubMed ID: 29745126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rubinstein-Taybi syndrome 2 with cerebellar abnormality and neural tube defect.
    Hadzsiev K; Gyorsok Z; Till A; Czakó M; Bartsch O
    Clin Dysmorphol; 2019 Jul; 28(3):137-141. PubMed ID: 30789376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.
    Caglayan AO; Lechno S; Gumus H; Bartsch O; Fryns JP
    Genet Couns; 2011; 22(4):341-6. PubMed ID: 22303793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome.
    Bartsch O; Rasi S; Delicado A; Dyack S; Neumann LM; Seemanová E; Volleth M; Haaf T; Kalscheuer VM
    Hum Genet; 2006 Sep; 120(2):179-86. PubMed ID: 16783566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into genotype-phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein-Taybi syndrome patients.
    Spena S; Milani D; Rusconi D; Negri G; Colapietro P; Elcioglu N; Bedeschi F; Pilotta A; Spaccini L; Ficcadenti A; Magnani C; Scarano G; Selicorni A; Larizza L; Gervasini C
    Clin Genet; 2015 Nov; 88(5):431-40. PubMed ID: 25388907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rubinstein-Taybi syndrome.
    Kosaki R
    Nihon Rinsho; 2017 Mar; 75(3):498-503. PubMed ID: 30566799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-specific mosaicism in a patient with Rubinstein-Taybi syndrome and CREBBP exon 1 duplication.
    Gucev ZS; Tasic VB; Saveski A; Polenakovic MH; Laban NB; Zechner U; Bartsch O
    Clin Dysmorphol; 2019 Jul; 28(3):142-144. PubMed ID: 30921089
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel heterozygous variants in the EP300 gene cause Rubinstein-Taybi syndrome 2: Reports from two Chinese children.
    Du C; Li Z; Zou B; Li X; Chen F; Liang Y; Luo X; Shu S
    Mol Genet Genomic Med; 2023 Sep; 11(9):e2192. PubMed ID: 37162176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.